ESC 365 - Reduction of thrombus burden by cangrelor in ticagrelor-loaded st-elevation myocardial infarction patients with high residual platelet reactivity: the imaging sub-study of the ERMIT randomized trial

ESC Premium Access

Reduction of thrombus burden by cangrelor in ticagrelor-loaded st-elevation myocardial infarction patients with high residual platelet reactivity: the imaging sub-study of the ERMIT randomized trial

Session: The guardians of clotting: exploring antiplatelet strategies

Topic: Adjunctive Pharmacotherapy

Speaker: Professor F. Beygui (Caen, FR)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Professor Farzin Beygui

University Hospital of Caen, Caen (France)

5 presentations

0 follower

5 more presentations in this session

Association of ticagrelor vs clopidogrel with net adverse clinical events in patients with mild thrombocytopenia undergoing PCI

Speaker: Professor K. Chen (Tianjin, CN)

Disparities in the proportion of ticagrelor and prasugrel-eligible patients with NSTE-ACS in a real-world registry

The safety and efficacy of indobufen or aspirin combined with clopidogrel in patients with acute myocardial infarction after percutaneous coronary intervention

Speaker: Doctor W. Dai (Tianjin, CN)

Respective impact of bleeding and ischemic complications of mortality after percutaneous coronary interventions: substudy from the FRANCE-PCI registry

Speaker: Doctor P. Guedeney (Paris, FR)

Complex versus non-complex, should we adjust the antiplatelet strategy to the type of percutaneous coronary intervention? Results from a real world PCI population

Speaker: Ms E. Woelders (Nijmegen, NL)

Access the full session

The guardians of clotting: exploring antiplatelet strategies

Speakers: Professor F. Beygui, Professor K. Chen, Doctor W. Dai, Doctor P. Guedeney, Ms E. Woelders

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources